Leadership Overview
MiMedx Group has 4 executives leading key functions including strategy, finance, medical affairs, and legal operations.
Driven by innovation, MiMedx Group is dedicated to developing and marketing regenerative biologics that leverage human placental tissue allografts, aiming to significantly advance patient care across diverse healthcare sectors through proprietary processing and biomaterial platforms.
Driven by innovation, MiMedx Group is dedicated to developing and marketing regenerative biologics that leverage human placental tissue allografts, aiming to significantly advance patient care across diverse healthcare sectors through proprietary processing and biomaterial platforms.
Leadership Roles at MiMedx Group
Joseph Capper - Chief Executive Officer
Joseph Capper, the Chief Executive Officer at MiMedx Group, directs the overarching corporate strategy and operational execution. Capper guides the company's mission to develop and market regenerative biologics derived from human placental tissue, focusing on patent-protected processes for broad healthcare applications. This leadership role involves steering the company's expansion into wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry markets. By overseeing the integration of proprietary biomaterial platforms like AmnioFix, EpiFix, OrthoFlo, Physio, and CollaFix, Capper ensures these technologies effectively augment tissue repair and regeneration. The Chief Executive Officer's focus remains on driving market penetration through both direct sales forces and strategic distribution partnerships, both domestically and internationally. Under Joseph Capper's direction, MiMedx Group aims to solidify its position as a leader in regenerative medicine, enhancing patient outcomes through advanced placental tissue-derived allografts and innovative processing methodologies.
Douglas Rice - Chief Financial Officer
Douglas Rice, the Chief Financial Officer at MiMedx Group, manages all financial operations and fiscal strategy. Rice oversees the company's financial planning, budgeting, and reporting, ensuring robust fiscal health as MiMedx Group expands its regenerative biologics portfolio. This executive function involves managing capital allocation for research and development of proprietary processes like the PURION Process, and for the commercialization of products such as AmnioFix and EpiCord. The Chief Financial Officer plays a critical part in evaluating market opportunities and financial risks associated with expanding into new therapeutic areas, including orthopedics, spine, and wound care. Rice's responsibilities extend to maintaining strong relationships with investors and financial institutions, securing the necessary funding to support the company's growth initiatives. By optimizing financial performance and resource management, Douglas Rice directly contributes to MiMedx Group's ability to deliver innovative solutions derived from human placental tissue to the global healthcare market.
David Mason - Chief Medical Officer
David Mason, the Chief Medical Officer at MiMedx Group, leads the clinical development and medical affairs strategy for the company's regenerative biologics. Mason directs the scientific validation and clinical application of products derived from human placental tissue, including AmnioFix, EpiFix, and CollaFix, ensuring their efficacy and safety across various medical disciplines. This critical role involves overseeing clinical trials, generating robust scientific data, and engaging with the medical community to advance the understanding and adoption of placental tissue allografts. The Chief Medical Officer's expertise is vital in guiding the company's product pipeline, particularly in areas such as wound care, orthopedics, and regenerative surgery. David Mason collaborates closely with the research and development teams to refine proprietary processing methodologies like the PURION Process, ensuring alignment with evolving clinical needs and regulatory standards. Through strategic medical leadership, Mason champions the therapeutic potential of MiMedx Group's biomaterials, driving innovation that improves patient outcomes.
William Hulse - General Counsel & Chief Administrative Officer
William Hulse, the General Counsel & Chief Administrative Officer at MiMedx Group, oversees all legal affairs and critical administrative functions. Hulse manages the company's legal framework, ensuring compliance with regulatory requirements across its diverse product lines, including regenerative biologics utilizing human placental tissue. This executive position involves safeguarding intellectual property related to proprietary processes such as the PURION Process and biomaterial platforms like AmnioFix and EpiCord. The General Counsel & Chief Administrative Officer also directs administrative operations, supporting the company's global expansion and its sales force engaged in markets ranging from wound care to orthopedics. William Hulse plays a key part in navigating complex legal landscapes, managing corporate governance, and ensuring the smooth operation of administrative departments that underpin MiMedx Group's business objectives. Hulse's comprehensive oversight provides a stable foundation for the company's continued innovation and market presence.
Explore Leadership Teams in Manufacturing
Siemens Healthineers, founded in 1847 and headquartered in Bavaria, Germany, is a global medical technology company specializing in manufacturing medical equipment and providing healthcare software solutions. The company offers a comprehensive portfolio of products and services in diagnostic imaging, laboratory diagnostics, and advanced therapies to help healthcare providers deliver high-quality patient care. Siemens Healthineers operates across multiple continents with a significant presence in Europe, North America, and Asia, serving hospitals, clinics, and medical facilities worldwide with innovative medical technology solutions.
Company Leadership SC
AA
RH
Founded in 1899, Dentsply Sirona is a manufacturer of professional dental products and technologies. The company develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a portfolio of brands. Dentsply Sironas global headquarters is located in York, Pennsylvania, and the international headquarters is based in Salzburg, Austria.
Company Leadership
LS
DC
Since 1997, the journey of Trivitron Healthcare as a medical technology company providing affordable healthcare solutions weaves a fascinating thread of inspiration to many healthcare providers. Having a solid expertise in research and development, Trivitron manufactures and distributes exceptional medical technology products.
Company Leadership GK
SS
BM
PP
Poly Medicure Limited, widely recognized under the Polymed brand, is a globally established medical device manufacturing company specializing in the development, production, and distribution of high-quality healthcare consumables and medical technologies. Headquartered in New Delhi, India, the organization has become one of the most prominent medical device manufacturers originating from India and has established a strong international footprint across healthcare markets worldwide. The company primarily operates within the medical technology and healthcare manufacturing sector, focusing on products that support hospitals, healthcare professionals, diagnostic centers, and patient care environments. The organization was founded with a vision to improve healthcare accessibility through innovative and reliable medical technologies. Since commencing manufacturing operations during the mid-nineteen nineties, the company has expanded from a small manufacturing operation into a globally recognized medical technology enterprise serving healthcare systems across numerous countries. The company’s growth has been driven by its strong emphasis on product innovation, advanced manufacturing capabilities, operational quality standards, and international expansion initiatives.
Company Leadership NV
RG
Frequently Asked Questions Regarding MiMedx Group Top Executives and Leadership Team
